INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on December 3, 2025, covering events occurring on November 26, 2025. The company is incorporated in Nevada and its common stock trades on The Nasdaq Capital Market under the symbol "IVF".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding the company's capital structure.
Material Changes
- Reverse Stock Split: The company effected a 1-for-8 reverse stock split of its issued and outstanding common stock.
- Effective Date: The split became effective at 12:01 a.m. Eastern Time on November 28, 2025.
- Authorized Shares: The company's authorized common stock was proportionately adjusted to 6,250,000 shares.
- Adjustments: Per share exercise prices and share counts for outstanding stock options and warrants were proportionately adjusted. No fractional shares were issued; holdings were rounded up to the next whole share.
- Trading Details: The stock continues to trade under the symbol "IVF" but was assigned a new CUSIP number (44984F807).
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the standard disclosure regarding the reverse stock split. The primary purpose of the filing is to disclose the amendment to the Articles of Incorporation via the Certificate of Change.
Investor Verification Checklist
- Verify the new CUSIP number (44984F807) for the company's common stock.
- Confirm the adjusted number of shares held in brokerage accounts following the 1-for-8 split.
- Review the updated terms of any outstanding stock options or warrants held, specifically the adjusted exercise prices and share quantities.
- Check the company's authorized share count, now set at 6,250,000 shares.